TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention
Status:
Terminated
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
Evaluate the survival without metastasis in patients treated by Trastuzumab in association
with other chemotherapies for a breast cancer expressing HER2-NEU.